Personalized Medicine and Cancer
Infographic Dec 11, 2019 | By Laura Elizabeth Lansdowne, Science Writer, Technology Networks
The aim of personalized medicine is to a move away from the traditional “one size fits all” approach to the treatment of diseases – such as cancer. For patients where standard clinical options have been exhausted, novel personalized therapeutics may be required.
Patient-derived cancer models, such as “organoids”, can help predict an individual’s response to a drug – both efficacy and toxicity – prior to administration.
Download this infographic to:
- Explore the challenges related to personalized medicine
- Compare three types of patient-derived model
- Discover how organoids can drive the development of personalized cancer treatments
Biotherapeutics now represent a rapidly growing portion of the pharmaceutical market. Download this infographic to learn more about what biotherapeutics are, why it is important to characterize and analyze them and four key approaches for biotherapeutic characterization and analysis.READ MORE
Both inductively coupled plasma optical emission spectroscopy (ICP-OES) and inductively coupled plasma mass spectrometry (ICP-MS) are analytical techniques important for the analysis of trace elements in a host of mediums. Download this infographic to learn more about these techniques and their uses.READ MORE